Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Articaine lozenge vs placebo for tolerability of upper gastrointestinal endoscopy
2012-005528-13Phase 4Completed
- Sponsor
- Helsinki University Hospital
- Start
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of articaine in Upper gastrointestinal tract disease (UGID) (3 arms), sponsored by Helsinki University Hospital. Primary endpoint: Primary tolerability endpoint. Started May 2014; status: completed.
02
Drugs
articaine
03
Conditions
Upper gastrointestinal tract disease (UGID)
Beyond the preview
Go deeper on 2012-005528-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-005528-13.